Breaking News

Bridgewest Group Launches NovaCina, New Sterile Injectable CDMO

Will manufacture sterile injectable drug products for all phases, from development to full scale commercial production.

Bridgewest Group, a company involved in developing innovative companies in life sciences, software, and deep tech, launched a new contract development and manufacturing organization (CDMO) focused on sterile injectable drug products. Located in Western Australia, the CDMO will operate under the name NovaCina. NovaCina will manufacture sterile injectable drug products for all phases, from development to full scale commercial production. It has over nine production lines across oncology/high po...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters